MedPath

Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions

Not Applicable
Conditions
Preterm labour.
Preterm labour without delivery
Registration Number
IRCT2015050119396N3
Lead Sponsor
Hormozgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

Between 26-34 weeks pregnancy age; There premature uterine contractions.
Exclusion criteria: the pregnancy age above 34 weeks (since in this group there would be no reason for preventing uterine contractions due to the fetal lung maturation); preterm rupture of membranes; corioamnionite, blood loss prior to the labor due to placental abruption or previa;multiple pregnancies; concomitant systemic diseases (preeclampsia, gestational diabetes (GDM); cardiovascular diseases; kidney diseases; asthma; hyperthyroid; …).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The prevention of preterm birth after inhibition of uterine contractions. Timepoint: 48 hours after the intervention. Method of measurement: Check up and examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath